Publication: Preserved amniotic membrane transplantation for conjunctival surface reconstruction
Issued Date
2001-09-01
Resource Type
ISSN
13899333
Other identifier(s)
2-s2.0-0034883771
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cell and Tissue Banking. Vol.2, No.1 (2001), 31-39
Suggested Citation
Pinnita Prabhasawat, Nattaporn Tesavibul Preserved amniotic membrane transplantation for conjunctival surface reconstruction. Cell and Tissue Banking. Vol.2, No.1 (2001), 31-39. doi:10.1023/A:1011597332277 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26556
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Preserved amniotic membrane transplantation for conjunctival surface reconstruction
Author(s)
Other Contributor(s)
Abstract
Objective. To study the efficacy of preserved human amniotic membrane in the reconstruction of conjunctival defect created during surgical removal of conjunctival lesions or symblepharon lysis. Methods. Preserved human amniotic membrane transplantation was performed in 93 eyes of 85 patients for reconstruction of various conjunctival surface problems. The indications for surgery were (1) pterygium excision (54 eyes), (2) conjunctival tumors excision (23 eyes), lysis of symblepharon (13 eyes), and covering a scleral graft (three eyes). Results. Success was noted in 69.9% (65/93) eyes, partially success in 22.6% (21/93) eyes, and failure in 7.5% (7/93) eyes with a mean follow-up of 8.9 months (1-28 months). In pterygium, conjunctival tumor, symblepharon, and scleral graft group, the success rate in each group was 70.3%, 78.3%, 53.8%, and 66.7% respectively. No serious immediate post-operative complications or graft rejection occurred. Conclusion. Amniotic membrane transplantation can be considered an alternative treatment for difficult ocular surface problems, and is effective in promoting epithelial healing, and reducing inflammation and scarring.